Menu

Star on GitHub · 3.2k

CVE-2024-25042

5.4 · MEDIUM

IBM Cognos Analytics 11.2.0 through 11.2.4 and 12.0.0 through 12.0.3 is potentially vulnerable to Cross Site Scripting (XSS).

Published Dec 18, 2024CWE-79EPSS 0.28%

Overview

CVE-2024-25042 is a medium-severity vulnerability. It was published on December 18, 2024 and has a CVSS 3.1 base score of 5.4 (MEDIUM).

This vulnerability has a CVSS 3.1 base score of 5.4, rated MEDIUM. It can be exploited remotely over the network. Some level of privileges is required for exploitation.

Technical description

IBM Cognos Analytics 11.2.0 through 11.2.4 and 12.0.0 through 12.0.3

is potentially vulnerable to Cross Site Scripting (XSS). A remote attacker could execute malicious commands due to improper validation of column headings in Cognos Explorations.

Remediation

Check the references section for vendor advisories, patches, and mitigation guidance. If immediate patching is not possible, review the CVSS vector to understand the attack surface and apply compensating controls such as network segmentation or access restrictions.

Frequently asked questions

What is CVE-2024-25042?

CVE-2024-25042 is a medium-severity vulnerability. It was published on December 18, 2024 and has a CVSS 3.1 base score of 5.4 (MEDIUM).

How severe is CVE-2024-25042?

This vulnerability has a CVSS 3.1 base score of 5.4, rated MEDIUM. It can be exploited remotely over the network. Some level of privileges is required for exploitation.

How do I fix or remediate CVE-2024-25042?

Check the references section for vendor advisories, patches, and mitigation guidance. If immediate patching is not possible, review the CVSS vector to understand the attack surface and apply compensating controls such as network segmentation or access restrictions.

How can CyberStrike help with CVE-2024-25042?

CyberStrike is an open-source, AI-augmented pentesting engine. Rather than flag a version number, it tests whether an issue like CVE-2024-25042 is actually reachable in your own applications and APIs, then verifies each finding before reporting it. That tells you if the weakness is a real, exploitable risk in your environment or a false positive you can safely deprioritize.

Related MEDIUM CVEs from 2024

View all